Latest From Biotech Now

| 06/25/2014

Biotech Market in Brazil is Booming!

LatinAmerica_205x100_Thumbnail copy

Brazil steps into the international spotlight as host of the 2014 World Cup and the 2016 Olympics as it celebrates a quarter century of democracy and political stability. The Brazilian economy – now the 7th largest globally by GDP (and averaging $57 billion in FDI inflows annually from 2008 to 2012) – is considered one of the most important in the world. Brazil has a number of innovation policies in place at the federal and Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , ,
| 06/25/2014

E&Y Super Session – Beyond Borders 2014 – Unlocking Value

Super Session

More than 500 attended the super session to go over key findings in the 28th annual EY Global Life Sciences Report: Beyond Borders, Unlocking Value. Glen Giovannetti, EY global life sciences sector leader, and Kristin Pothier, partner in the EY commercial advisory services, moderated. Panelists were: Mara Aspinali, president and CEO of Ventana Medical Systems; Philip Birch, senior vice president, global strategic marketing, Aptiv Solutions; Brian Daniels, M.D., senior vice president, global development and medical Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , ,
Iestyn Armstrong-Smith | 06/25/2014

Digital Health in a Mobile World

DigitalHealth-728x90

Healthcare is shaping up to be an important area for all the big technology companies that focus on mobile devices. And that is pretty much all of them. When Sony sold off its VAIO computer division to Japan Industrial Partners earlier this year, among the reasons given were “drastic changes in the global PC industry”, and a need to “concentrate on … smartphones and tablets.” Over at Microsoft, new CEO Satya Nadella says we’ve entered Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,
Iestryn Armstrong-Smith | 06/25/2014

Making it Personal

making-it-personal copy

The “valley of death” between drug discovery and the development and provision of therapy is a huge issue in biotech. Recent news, however, highlights valiant entrepreneurs who look at the chasm and are building bridges to cross it. One of these is Ilan Ganot whose son, Eytani, was diagnosed with Duchenne muscular dystrophy (DMD) at the age of two years old. The ex-hedge fund banker at JPMorgan Chase & Co quit his job in London, Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,
Iestyn Armstrong-Smith | 06/25/2014

My Regeneration

brain-scan

What can today’s generation hope for from regenerative medicine? It’s a frontier for business, the medical profession and society. Regenerative medicine aims to shift the focus from palliative care to the development of treatments that address diabetes, Parkinson’s disease, stroke and heart disease. The hope is that we’ll live longer, healthier lives and have greater independence in old age, thereby reducing the burden on healthcare systems. Given global population demographics, this is essential: according to the World Health Organisation by Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , ,